Go to
JCI Insight
Citations to this article
D. Brenda Salantes, … , Pablo Tebas, Katharine J. Bar
Published June 18, 2018
Citation Information: J Clin Invest. 2018;128(7):3102-3115. https://doi.org/10.1172/JCI120194.
Citation Information: J Clin Invest. 2018;128(7):3102-3115. https://doi.org/10.1172/JCI120194.
Abstract
BACKGROUND. The effect of a brief analytical treatment interruption (ATI) on the HIV-1 latent reservoir of individuals who initiate antiretroviral therapy (ART) during chronic infection is unknown. METHODS. We evaluated the impact of transient viremia on the latent reservoir in participants who underwent an ATI and at least 6 months of subsequent viral suppression in a clinical trial testing the effect of passive infusion of the broadly neutralizing Ab VRC01 during ATI. RESULTS. Measures of total HIV-1 DNA, cell-associated RNA, and infectious units per million cells (IUPM) (measured by quantitative viral outgrowth assay [QVOA]) were not statistically different before or after ATI. Phylogenetic analyses of HIV-1 env sequences from QVOA and proviral DNA demonstrated little change in the composition of the virus populations comprising the pre- and post-ATI reservoir. Expanded clones were common in both QVOA and proviral DNA sequences. The frequency of clonal populations differed significantly between QVOA viruses, proviral DNA sequences, and the viruses that reactivated in vivo. CONCLUSIONS. The results indicate that transient viremia from ATI does not substantially alter measures of the latent reservoir, that clonal expansion is prevalent within the latent reservoir, and that characterization of latent viruses that can reactivate in vivo remains challenging. TRIAL REGISTRATION. ClinicalTrials.gov NCT02463227 FUNDING. Funding was provided by the NIH.
Authors
D. Brenda Salantes, Yu Zheng, Felicity Mampe, Tuhina Srivastava, Subul Beg, Jun Lai, Jonathan Z. Li, Randall L. Tressler, Richard A. Koup, James Hoxie, Mohamed Abdel-Mohsen, Scott Sherrill-Mix, Kevin McCormick, E. Turner Overton, Frederic D. Bushman, Gerald H. Learn, Robert F. Siliciano, Janet M. Siliciano, Pablo Tebas, Katharine J. Bar
Total citations by year
Citation information
Citations to this article (76)
| Title and authors | Publication | Year |
|---|---|---|
|
HIV-1 Rebound Virus Consists of a Small Number of Lineages That Entered the Reservoir Close to ART Initiation
Tyers L, Moeser M, Ntuli J, Council O, Zhou S, Spielvogel E, Sondgeroth A, Adams C, Thebus R, Yssel A, Karim SA, Garrett N, Pond SK, Williamson C, Swanstrom R, Abrahams MR, Joseph SB |
bioRxiv | 2025 |
|
HIV Cerebrospinal Fluid Escape: Interventions for the Management, Current Evidence and Future Perspectives
Kelly SH, Nightingale S, Gupta RK, Collier DA |
Tropical Medicine and Infectious Disease | 2025 |
|
Clinical trials of broadly neutralizing monoclonal antibodies in people living with HIV – a review
Mahomed S, Pillay K, Hassan-Moosa R, Galvão BP, Burgers WA, Moore PL, Rose-Abrahams M, Williamson C, Garrett N |
AIDS Research and Therapy | 2025 |
|
Sirolimus reduces T cell cycling, immune checkpoint marker expression and HIV-1 DNA in people with HIV (results of the ACTG A5337 study)
Timothy Henrich, Ronald Bosch, Catherine Godfrey, Hanna Mar, Apsara Nair, Michael Keefer, Carl Fichtenbaum, Daniela Moisi, Brian Clagett, Amanda Buck, Amelia Deitchman, Francesca Aweeka, Jonathan Li, Daniel Kuritzkes, Michael Lederman, Priscilla Hsue, Steven Deeks |
Cell reports. Medicine | 2024 |
|
Autologous neutralizing antibody responses after antiretroviral therapy in acute and early HIV-1.
Gregory Whitehill, Jaimy Joy, Francesco Marino, Ryan Krause, Suvadip Mallick, Kyewon Park, John Carey, Rebeccah Hoh, Heather Hartig, Vivian Pae, Sannidhi Sarvadhavabhatla, Sophia Donaire, Steven Deeks, Rebecca Lynch, Sulggi Lee, Katharine Bar |
Journal of Clinical Investigation | 2024 |
|
Validation and real-world experience of a neutralization sensitivity assay for broadly neutralizing anti-HIV-1 antibodies.
Marie H. Pahus, Yu Zheng, Maxine Olefsky, Jesper Gunst, Pablo Tebas, Babafemi Taiwo, Ole Søgaard, Michael Peluso, Yolanda Lie, Jacqueline Reeves, Christos Petropoulos, Marina Caskey, Katharine Bar |
The Journal of infectious diseases | 2024 |
|
The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time
Shahid A, MacLennan S, Jones BR, Sudderuddin H, Dang Z, Cobarrubias K, Duncan MC, Kinloch NN, Dapp MJ, Archin NM, Fischl MA, Ofotokun I, Adimora A, Gange S, Aouizerat B, Kuniholm MH, Kassaye S, Mullins JI, Goldstein H, Joy JB, Anastos K, Brumme ZL |
Journal of virology | 2024 |
|
Low-level viremia episodes appear to affect the provirus composition of the circulating cellular HIV reservoir during antiretroviral therapy
Sun X, Zhang H, Kong X, Li N, Zhang T, An M, Ding H, Shang H, Han X |
Frontiers in microbiology | 2024 |
|
The impact of analytical treatment interruptions and trial interventions on time to viral re‐suppression in people living with HIV restarting ART in cure‐related clinical studies: a systematic review and meta‐analysis
Lee MJ, Eason M, Castagna A, Laura G, De Scheerder M, Riley J, Tebas P, Gunst J, Søgaard O, Florence E, Kroon E, De Souza M, Mothe B, Caskey M, Fidler S |
Journal of the International AIDS Society | 2024 |
|
Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruption.
Pereira Ribeiro S, Strongin Z, Soudeyns H, Ten-Caten F, Ghneim K, Pacheco Sanchez G, Xavier de Medeiros G, Del Rio Estrada PM, Pelletier AN, Hoang T, Nguyen K, Harper J, Jean S, Wallace C, Balderas R, Lifson JD, Raghunathan G, Rimmer E, Pastuskova C, Wu G, Micci L, Ribeiro RM, Chan CN, Estes JD, Silvestri G, Gorman DM, Howell BJ, Hazuda DJ, Paiardini M, Sekaly RP |
Nature immunology | 2024 |
|
HIV Reservoir: How to Measure It?
Zhang X, Chen J |
Current HIV/AIDS Reports | 2023 |
|
HIV reservoirs are dominated by genetically younger and clonally enriched proviruses
Kinloch NN, Shahid A, Dong W, Kirkby D, Jones BR, Beelen CJ, MacMillan D, Lee GQ, Mota TM, Sudderuddin H, Barad E, Harris M, Brumme CJ, Jones RB, Brockman MA, Joy JB, Brumme ZL |
2023 | |
|
The latent reservoir of inducible, replication-competent HIV-1 does not decrease despite decades of antiretroviral therapy
Natalie F McMyn, Joseph Varriale, Emily J Fray, Carolin Zitzmann, Hannah MacLeod, Jun Lai, Anushka Singhal, Milica Moskovljevic, Mauro A Garcia, Brianna M Lopez, Vivek Hariharan, Kyle Rhodehouse, Kenneth Lynn, Pablo Tebas, Karam Mounzer, Luis Montaner, Erika Benko, Colin Kovacs, Rebecca Hoh, Francesco Simonetti, Gregory Laird, Steven Deeks, Ruy Ribeiro, Alan Perelson, Robert Siliciano, Janet Siliciano |
Journal of Clinical Investigation | 2023 |
|
Antiretroviral treatment interruption and resumption within 16 weeks among HIV-positive adults in Jinan, China: a retrospective cohort study
Ma J, Jin Y, Jiao K, Wang Y, Gao L, Li X, Ma W |
Frontiers in public health | 2023 |
|
Preferential selection of viral escape mutants by CD8+ T cell ‘sieving’ of SIV reactivation from latency
Docken SS, McCormick K, Pampena MB, Samer S, Lindemuth E, Pinkevych M, Viox EG, Wu Y, Schlub TE, Cromer D, Keele BF, Paiardini M, Betts MR, Bar KJ, Davenport MP |
PLoS pathogens | 2023 |
|
HIV reservoirs are dominated by genetically younger and clonally enriched proviruses
Kinloch NN, Shahid A, Dong W, Kirkby D, Jones BR, Beelen CJ, MacMillan D, Lee GQ, Mota TM, Sudderuddin H, Barad E, Harris M, Brumme CJ, Jones RB, Brockman MA, Joy JB, Brumme ZL |
mBio | 2023 |
|
Development of Screening Assays for Use of Broadly Neutralizing Antibodies in People Living with HIV
Lynch RM, Bar KJ |
Current opinion in HIV and AIDS | 2023 |
|
Plasma-Derived HIV-1 Virions Contain Considerable Levels of Defective Genomes
K Fisher, X Wang, A Lee, V Morcilla, A de Vries, E Lee, J Eden, S Deeks, A Kelleher, S Palmer |
Journal of virology | 2022 |
|
Viral and Host Biomarkers of HIV Remission Post Treatment Interruption
L Giron, M Abdel-Mohsen |
Current HIV/AIDS Reports | 2022 |
|
Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda
S Joussef-Piña, I Nankya, S Nalukwago, J Baseke, S Rwambuya, D Winner, F Kyeyune, K Chervenak, B Thiel, R Asaad, C Dobrowolski, B Luttge, B Lawley, C Kityo, W Boom, J Karn, M Quiñones-Mateu |
Retrovirology | 2022 |
|
HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies
E Kreider, K Bar |
Current HIV/AIDS Reports | 2022 |
|
Identification, Quantification, and Characterization of HIV-1 Reservoirs in the Human Brain
Donoso M, D\u2019Amico D, Valdebenito S, Hernandez CA, Prideaux B, Eugenin EA |
Cells | 2022 |
|
Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design
Lau JS, Cromer D, Pinkevych M, Lewin SR, Rasmussen TA, McMahon JH, Davenport MP |
The Journal of Infectious Diseases | 2022 |
|
Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated Patients
Nicolas A, Migraine J, Dutrieux J, Salmona M, Tauzin A, Hachiya A, Estaquier J, Molina JM, Clavel F, Hance AJ, Mammano F |
Microbiology spectrum | 2022 |
|
Bispecific antibody-derived molecules to target persistent HIV infection.
Nordstrom JL, Ferrari G, Margolis DM |
Journal of virus eradication | 2022 |
|
Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption
Cole B, Lambrechts L, Boyer Z, Noppe Y, De Scheerder MA, Eden JS, Vrancken B, Schlub TE, McLaughlin S, Frenkel LM, Palmer S, Vandekerckhove L |
Cell Reports | 2022 |
|
Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+ T cell reservoir
Wu VH, Nordin JM, Nguyen S, Joy J, Mampe F, del Rio Estrada PM, Torres-Ruiz F, González-Navarro M, Luna-Villalobos YA, Ávila-Ríos S, Reyes-Terán G, Tebas P, Montaner LJ, Bar KJ, Vella LA, Betts MR |
Nature Immunology | 2022 |
|
Brief Report: Rebound HIV viremia with meningoencephalitis following antiretroviral therapy interruption after allogeneic bone marrow transplant
Capoferri AA, Redd AD, Gocke CD, Clark LR, Quinn TC, Ambinder RF, Durand CM |
Journal of acquired immune deficiency syndromes (1999) | 2022 |
|
CCR5-edited CD4 T cells augment HIV-specific immunity to enable post rebound control of HIV replication
Pablo Tebas, Julie K. Jadlowsky, Pamela A Shaw, Lifeng Tian, Erin Esparza, Andrea Brennan, SuKyung Kim, SoeYu Naing, Max W. Richardson, Ashley N Vogel, Colby R Maldini, Hong Kong, Xiaojun Liu, Simon F. Lacey, Anya M Bauer, Felicity Mampe, Lee P Richman, Gary Lee, Dale Ando, Bruce L. Levine, David L Porter, Yangbing Zhao, Don L Siegel, Katharine Bar, Carl June, James L. Riley |
Journal of Clinical Investigation | 2021 |
|
Engaging innate immunity in HIV-1 cure strategies
NL Board, M Moskovljevic, F Wu, RF Siliciano, JD Siliciano |
Nature Reviews Immunology | 2021 |
|
Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption
MV Gondim, S Sherrill-Mix, F Bibollet-Ruche, RM Russell, S Trimboli, AG Smith, Y Li, W Liu, AN Avitto, JC DeVoto, J Connell, AE Fenton-May, P Pellegrino, I Williams, E Papasavvas, JC Lorenzi, DB Salantes, F Mampe, MA Monroy, YZ Cohen, S Heath, MS Saag, LJ Montaner, RG Collman, JM Siliciano, RF Siliciano, LJ Plenderleith, PM Sharp, M Caskey, MC Nussenzweig, GM Shaw, P Borrow, KJ Bar, BH Hahn |
Science Translational Medicine | 2021 |
|
Quantifying the clonality and dynamics of the within-host HIV-1 latent reservoir
RC Ferreira, JL Prodger, AD Redd, AF Poon |
Virus Evolution | 2021 |
|
The Clonal Expansion Dynamics of the HIV-1 Reservoir: Mechanisms of Integration Site-Dependent Proliferation and HIV-1 Persistence
YH Yeh, K Yang, A Razmi, YC Ho |
Viruses | 2021 |
|
In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of plasma viremia
B Cole, L Lambrechts, P Gantner, Y Noppe, N Bonine, W Witkowski, L Chen, S Palmer, JI Mullins, N Chomont, M Pardons, L Vandekerckhove |
Nature Communications | 2021 |
|
New Approaches to Multi-Parametric HIV-1 Genetics Using Multiple Displacement Amplification: Determining the What, How, and Where of the HIV-1 Reservoir
SC Patro, A Niyongabo, F Maldarelli, MF Kearney |
Viruses | 2021 |
|
Early Initiation of Antiretroviral Therapy Following In Utero HIV Infection Is Associated With Low Viral Reservoirs but Other Factors Determine Viral Rebound
JR Millar, N Bengu, VA Vieira, E Adland, J Roider, M Muenchhoff, R Fillis, K Sprenger, V Ntlantsana, I Fatti, M Archary, A Groll, N Ismail, MC García-Guerrero, PC Matthews, T Ndungu, MC Puertas, J Martinez-Picado, P Goulder |
The Journal of Infectious Diseases | 2021 |
|
Motivations, barriers and experiences of participants in an HIV reservoir trial
MA Scheerder, WP van Bilsen, M Dullaers, J Martinez-Picado, U Davidovich, L Vandekerckhove |
Journal of virus eradication | 2021 |
|
Transient viral replication during analytical treatment interruptions in SIV infected macaques can alter the rebound-competent viral reservoir
TT Immonen, CM Fennessey, L Lipkey, A Thorpe, GQ Prete, JD Lifson, MP Davenport, BF Keele, U ODoherty |
PLoS pathogens | 2021 |
|
Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations
L Zheng, C Tierney, RJ Bosch |
Current HIV/AIDS Reports | 2021 |
|
Safety, Immune, and Antiviral Effects of Pegylated Interferon Alpha 2b Administration in Antiretroviral Therapy-Suppressed Individuals: Results of Pilot Clinical Trial
E Papasavvas, L Azzoni, A Pagliuzza, M Abdel-Mohsen, BN Ross, M Fair, BJ Howell, DJ Hazuda, N Chomont, Q Li, K Mounzer, JR Kostman, P Tebas, LJ Montaner |
AIDS Research and Human Retroviruses | 2021 |
|
Impact of Analytical Treatment Interruption on Burden and Diversification of HIV Peripheral Reservoir: A Pilot Study
R Scutari, V Costabile, L Galli, MC Bellocchi, L Carioti, S Barbaliscia, A Poli, A Galli, CF Perno, MM Santoro, A Castagna, F Ceccherini-Silberstein, C Alteri, V Spagnuolo |
Viruses | 2021 |
|
Characterizing the Relationship Between Neutralization Sensitivity and env Gene Diversity During ART Suppression
A Wilson, L Shakhtour, A Ward, Y Ren, M Recarey, E Stevenson, M Korom, C Kovacs, E Benko, RB Jones, RM Lynch |
Frontiers in immunology | 2021 |
|
Design and implementation of a cohort study of persons living with HIV infection who are initiating medication treatment for opioid use disorder to evaluate HIV-1 persistence
A Schultheis, M Sanchez, S Pedersen, T Kyriakides, YC Ho, Y Kluger, SA Springer |
Contemporary Clinical Trials Communications | 2021 |
|
Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy
Annukka A. R. Antar, Katharine M. Jenike, Sunyoung Jang, Danielle N. Rigau, Daniel B. Reeves, Rebecca Hoh, Melissa R. Krone, Jeanne C. Keruly, Richard D. Moore, Joshua T. Schiffer, Bareng A.S. Nonyane, Frederick M. Hecht, Steven G. Deeks, Janet D. Siliciano, Ya-Chi Ho, Robert F. Siliciano |
Journal of Clinical Investigation | 2020 |
|
Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections
Anderson, Simonetti, Gorelick, Hill, Gouzoulis, Bell, Rehm, Pérez, Boritz, Wu, Wells, Hughes, Rao, Coffin, Kearney, Maldarelli |
Viruses | 2020 |
|
The HIV-1 latent reservoir is largely sensitive to circulating T cells
JA Warren, S Zhou, Y Xu, MJ Moeser, DR MacMillan, O Council, J Kirchherr, JM Sung, NR Roan, AA Adimora, S Joseph, JA Kuruc, CL Gay, DM Margolis, N Archin, ZL Brumme, R Swanstrom, N Goonetilleke |
eLife | 2020 |
|
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption
J Harper, S Gordon, CN Chan, H Wang, E Lindemuth, C Galardi, SD Falcinelli, SL Raines, JL Read, K Nguyen, CS McGary, M Nekorchuk, K Busman-Sahay, J Schawalder, C King, M Pino, L Micci, B Cervasi, S Jean, A Sanderson, B Johns, AA Koblansky, H Amrine-Madsen, J Lifson, DM Margolis, G Silvestri, KJ Bar, D Favre, JD Estes, M Paiardini |
Nature Medicine | 2020 |
|
Experimental Systems for Measuring HIV Latency and Reactivation
K Fujinaga, DC Cary |
Viruses | 2020 |
|
Pre-existing resistance in the latent reservoir can compromise VRC01 therapy during chronic HIV-1 infection
A Saha, NM Dixit, RD Kouyos |
PLoS computational biology | 2020 |
|
The forces driving clonal expansion of the HIV-1 latent reservoir
R Liu, FR Simonetti, YC Ho |
Virology Journal | 2020 |
|
Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment
HA Aamer, J McClure, D Ko, J Maenza, AC Collier, RW Coombs, JI Mullins, LM Frenkel, DC Douek |
PLoS pathogens | 2020 |
|
CD8+ T cells in HIV control, cure and prevention
DR Collins, GD Gaiha, BD Walker |
Nature Reviews Immunology | 2020 |
|
Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs
A Ait-Ammar, A Kula, G Darcis, R Verdikt, SD Wit, V Gautier, PW Mallon, A Marcello, O Rohr, CV Lint |
Frontiers in microbiology | 2020 |
|
Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound
MR López-Huertas, C Gutiérrez, N Madrid-Elena, B Hernández-Novoa, J Olalla-Sierra, M Plana, R Delgado, R Rubio, MÁ Muñoz-Fernández, S Moreno |
Scientific Reports | 2020 |
|
HIV-1 Persistence and Chronic Induction of Innate Immune Responses in Macrophages
H Akiyama, S Gummuluru |
Viruses | 2020 |
|
Recommendations for measuring HIV reservoir size in cure-directed clinical trials
M Abdel-Mohsen, D Richman, RF Siliciano, MC Nussenzweig, BJ Howell, J Martinez-Picado, N Chomont, KJ Bar, XG Yu, M Lichterfeld, J Alcami, D Hazuda, F Bushman, JD Siliciano, MR Betts, AM Spivak, V Planelles, BH Hahn, DM Smith, YC Ho, MJ Buzon, C Gaebler, M Paiardini, Q Li, JD Estes, TJ Hope, J Kostman, K Mounzer, M Caskey, L Fox, I Frank, JL Riley, P Tebas, LJ Montaner |
Nature Medicine | 2020 |
|
Nonstructured Treatment Interruptions Are Associated With Higher Human Immunodeficiency Virus Reservoir Size Measured by Intact Proviral DNA Assay in People Who Inject Drugs
GD Kirk, J Astemborski, SH Mehta, KD Ritter, GM Laird, R Bordi, R Sekaly, JD Siliciano, RF Siliciano |
The Journal of Infectious Diseases | 2020 |
|
Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1
LN Bertagnolli, J Varriale, S Sweet, J Brockhurst, FR Simonetti, J White, S Beg, K Lynn, K Mounzer, I Frank, P Tebas, KJ Bar, LJ Montaner, RF Siliciano, JD Siliciano |
Proceedings of the National Academy of Sciences | 2020 |
|
Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on‐going viral transcription
P Pannus, S Rutsaert, SD Wit, SD Allard, G Vanham, B Cole, C Nescoi, J Aerts, WD Spiegelaere, A Tsoumanis, MM Couttenye, N Herssens, MA Scheerder, L Vandekerckhove, E Florence |
Journal of the International AIDS Society | 2020 |
|
Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption
MA Scheerder, CV Hecke, H Zetterberg, D Fuchs, ND Langhe, S Rutsaert, B Vrancken, W Trypsteen, Y Noppe, BV Gucht, J Pelgrom, FV Wanzeele, S Palmer, P Lemey, M Gisslén, L Vandekerckhove |
Journal of Antimicrobial Chemotherapy | 2020 |
|
Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response
L Leal, C Fehér, V Richart, B Torres, F García |
Human vaccines | 2020 |
|
Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency Virus
J Hellmuth, C Muccini, DJ Colby, E Kroon, M de Souza, TA Crowell, P Chan, C Sacdalan, J Intasan, K Benjapornpong, S Tipsuk, S Puttamaswin, N Chomchey, V Valcour, M Sarnecki, F Tomaka, SJ Krebs, BM Slike, LL Jagodzinski, N Dumrongpisutikul, N Sailasuta, V Samboju, NL Michael, ML Robb, S Vasan, J Ananworanich, P Phanuphak, N Phanuphak, R Paul, S Spudich |
Clinical Infectious Diseases | 2020 |
|
The Paradox of HIV Blood–Brain Barrier Penetrance and Antiretroviral Drug Delivery Deficiencies
O Osborne, N Peyravian, M Nair, S Daunert, M Toborek |
Trends in Neurosciences | 2020 |
|
CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV
GB Kim, K Hege, JL Riley |
Frontiers in immunology | 2019 |
|
Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals
ER Wonderlich, K Subramanian, B Cox, A Wiegand, C Lackman-Smith, MJ Bale, M Stone, R Hoh, MF Kearney, F Maldarelli, SG Deeks, MP Busch, RG Ptak, DA Kulpa, DM Margolis |
PLoS pathogens | 2019 |
|
HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study
MR López-Huertas, C Palladino, M Garrido-Arquero, B Esteban-Cartelle, M Sánchez-Carrillo, P Martínez-Román, L Martín-Carbonero, P Ryan, L Domínguez-Domínguez, ID Santos, SD Moral, JM Benito, N Rallón, J Alcamí, S Resino, A Fernández-Rodríguez, M Coiras, V Briz |
Scientific Reports | 2019 |
|
Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption
LK Vibholm, JC Lorenzi, JA Pai, YZ Cohen, TY Oliveira, JP Barton, MG Noceda, CL Lu, Y Ablanedo-Terrazas, PM Estrada, G Reyes-Teran, M Tolstrup, PW Denton, T Damsgaard, OS Søgaard, MC Nussenzweig, G Silvestri |
Journal of virology | 2019 |
|
Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4 + T Cell Subsets during Long-Term Combination Antiretroviral Therapy
BR Jones, RL Miller, NN Kinloch, O Tsai, H Rigsby, H Sudderuddin, A Shahid, B Ganase, CJ Brumme, M Harris, AF Poon, MA Brockman, R Fromentin, N Chomont, JB Joy, ZL Brumme, G Silvestri |
Journal of virology | 2019 |
|
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting
B Julg, L Dee, J Ananworanich, DH Barouch, K Bar, M Caskey, DJ Colby, L Dawson, KL Dong, K Dubé, J Eron, J Frater, RT Gandhi, R Geleziunas, P Goulder, GJ Hanna, R Jefferys, R Johnston, D Kuritzkes, JZ Li, U Likhitwonnawut, J van Lunzen, J Martinez-Picado, V Miller, LJ Montaner, DF Nixon, D Palm, G Pantaleo, H Peay, D Persaud, J Salzwedel, K Salzwedel, T Schacker, V Sheikh, OS Søgaard, S Spudich, K Stephenson, J Sugarman, J Taylor, P Tebas, CT Tiemessen, R Tressler, CD Weiss, L Zheng, ML Robb, NL Michael, JW Mellors, SG Deeks, BD Walker |
The Lancet HIV | 2019 |
|
No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized Trial
JZ Li, PE Sax, VC Marconi, J Fajnzylber, B Berzins, AN Nyaku, CJ Fichtenbaum, T Wilkin, CA Benson, SL Koletar, R Lorenzo-Redondo, BO Taiwo |
Open Forum Infectious Diseases | 2019 |
|
Impact of Treatment Interruption on HIV Reservoirs and Lymphocyte Subsets in Individuals Who Initiated Antiretroviral Therapy During the Early Phase of Infection
ED Huiting, K Gittens, JS Justement, V Shi, J Blazkova, E Benko, C Kovacs, PA Wender, S Moir, MC Sneller, AS Fauci, TW Chun |
The Journal of Infectious Diseases | 2019 |
|
Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestors
SC Patro, LD Brandt, MJ Bale, EK Halvas, KW Joseph, W Shao, X Wu, S Guo, B Murrell, A Wiegand, J Spindler, C Raley, C Hautman, M Sobolewski, CM Fennessey, WS Hu, B Luke, JM Hasson, A Niyongabo, AA Capoferri, BF Keele, J Milush, R Hoh, SG Deeks, F Maldarelli, SH Hughes, JM Coffin, JW Rausch, JW Mellors, MF Kearney |
Proceedings of the National Academy of Sciences | 2019 |
|
HIV Rebound Is Predominantly Fueled by Genetically Identical Viral Expansions from Diverse Reservoirs
De Scheerder MA, Vrancken B, Dellicour S, Schlub T, Lee E, Shao W, Rutsaert S, Verhofstede C, Kerre T, Malfait T, Hemelsoet D, Coppens M, Dhondt A, Looze DD, Vermassen F, Lemey P, Palmer S, Vandekerckhove L |
Cell Host & Microbe | 2019 |
|
Highlights from the Fourth Biennial Strategies for an HIV Cure Meeting, 10–12 October 2018, Bethesda, MD, USA
Kuo L, Lawrence D, McDonald D, Refsland E, Bridges S, Smiley S, Tressler RL, Beaubien C, Salzwedel K |
Journal of Virus Eradication | 2019 |
|
Relationship between intact HIV-1 proviruses in circulating CD4 + T cells and rebound viruses emerging during treatment interruption
CL Lu, JA Pai, L Nogueira, P Mendoza, H Gruell, TY Oliveira, J Barton, JC Lorenzi, YZ Cohen, LB Cohn, F Klein, M Caskey, MC Nussenzweig, M Jankovic |
Proceedings of the National Academy of Sciences | 2018 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)